Press "esc" to clear
Go to Advanced Search

Showing results

110 of 428
ChenBrain.jpg
  • Embargo expired:
    26-Apr-2018 5:00 AM EDT

Article ID: 693499

Noninvasive Brain Tumor Biopsy on the Horizon

Washington University in St. Louis

Taking a biopsy of a brain tumor is a complicated and invasive surgical process, but a team of researchers at Washington University in St. Louis is developing a way that allows them to detect tumor biomarkers through a simple blood test.

Released:
26-Apr-2018 5:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
RMIObesityNeuronsCrop1_.jpg

Article ID: 693183

Scientists Re-Create Brain Neurons to Study Obesity and Personalize Treatment

Cedars-Sinai

Scientists have re-created brain neurons of obese patients using "disease in a dish" technology, offering a new method to study the brain's role in obesity and possibly help tailor treatments to specific individuals.

Released:
19-Apr-2018 4:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites

Article ID: 692594

Ludwig Scientists Share New Findings on Personalized Cancer Treatments, Immunotherapy and the Tumor Microenvironment at 2018 AACR Annual Meeting

Ludwig Cancer Research

Ludwig Cancer Research released today the full scope of findings to be presented by Ludwig researchers at this year’s American Association for Cancer Research (AACR) Annual Meeting in Chicago, Ill., April 14-18, 2018. Research conducted by more than 100 Ludwig scientists will be presented in symposiums, plenaries, town meetings, education sessions and poster sessions.

Released:
11-Apr-2018 4:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    11-Apr-2018 2:00 PM EDT

Article ID: 692610

Personalized Tumor Vaccine Shows Promise in Pilot Trial

Perelman School of Medicine at the University of Pennsylvania

A new type of cancer vaccine has yielded promising results in an initial clinical trial. The personalized vaccine is made from patients’ own immune cells, which are exposed to the contents of the patients’ tumor cells, and then injected into the patients to initiate a wider immune response. The trial, conducted in advanced ovarian cancer patients, was a pilot trial aimed primarily at determining safety and feasibility, but there were clear signs that it could be effective: About half of the vaccinated patients showed signs of anti-tumor T-cell responses, and those “responders” tended to live much longer without tumor progression than those who didn’t respond. The study is published today in Science Translational Medicine.

Released:
11-Apr-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Akbani_Rehani.jpg
  • Embargo expired:
    5-Apr-2018 12:00 PM EDT

Article ID: 692259

Findings From Breast and Gynecological Cancer Study May Have Potential for Future Clinical Applications

University of Texas M. D. Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center have found a startling amount of new information about molecular features of tumors as well as identified previously unknown cancer subtypes based on a comprehensive analysis of 2,579 tumors from breast and four different types of gynecologic cancers. These new findings potentially could serve as a launching pad for future therapeutic studies.

Released:
4-Apr-2018 3:25 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 692244

Faster Diagnostics, Personalized Antibiotics Needed to Halt Superbugs

Cornell University

Released:
4-Apr-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
  • Embargo expired:
    4-Apr-2018 11:00 AM EDT

Article ID: 692216

Get Your Colour On, Canada! The Princess Margaret Launches “Colour Your Hair to Conquer Cancer”

University Health Network (UHN)

The Princess Margaret Cancer Foundation announces the launch of Colour Your Hair to Conquer Cancer, a bold and engaging new fundraising initiative benefiting the Princess Margaret Cancer Centre.

Released:
4-Apr-2018 11:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 692162

PhRMA Foundation 2018 Value Assessment Challenge Awards to Focus on Personalized Medicine

PhRMA Foundation

The PhRMA Foundation will be partnering with the Personalized Medicine Coalition (PMC) to offer Value Assessment Challenge Awards in 2018, providing more than $80,000 to support scientific papers that advance solutions to a question: What are potentially transformative strategies and methods to define and measure value at all levels of decision making that are aligned with personalized/precision medicine?

Released:
3-Apr-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Astrocytes1.jpg

Article ID: 691801

Gene Therapy May Help Brain Heal From Stroke, Other Injuries

UT Southwestern Medical Center

Scientists have found a genetic trigger that may improve the brain’s ability to heal from a range of debilitating conditions, from strokes to concussions and spinal cord injuries.

Released:
27-Mar-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
BowelCancer.jpg

Article ID: 691470

Researchers at Queen’s Lead ‘Personalised Medicine’ Approach to Improve Quality of Life for Bowel Cancer Patients

Queen's University Belfast

Researchers from Queen’s University Belfast have demonstrated for the first time how molecular analysis of clinical trial biopsy samples can be used to help clinicians identify the key changes that occur in an individual patient’s bowel (colorectal) tumour prior to surgery, so clinicians can better understand and treat the disease.

Released:
21-Mar-2018 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 428





Chat now!